DNA methylation changes in hematologic malignancies: biologic and clinical implications.
DNA methylation changes are among the most common detectable abnormalities in human
neoplasia. Hypermethylation within the promoters of selected genes appears to be …
neoplasia. Hypermethylation within the promoters of selected genes appears to be …
DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia
B Rüter, PW Wijermans, M Lübbert - International journal of hematology, 2004 - Springer
DNA methylation provides a major epigenetic code (besides histone modification) of the
lineage-and developmentspecific genes (such as regulators of differentiation in the …
lineage-and developmentspecific genes (such as regulators of differentiation in the …
Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS
DNA methylation abnormalities have recently emerged as one of the most frequent
molecular changes in hematopoietic neoplasms. Since methylation and transcriptional …
molecular changes in hematopoietic neoplasms. Since methylation and transcriptional …
Role of epigenetic changes in hematological malignancies
U Lehmann, K Brakensiek, H Kreipe - Annals of hematology, 2004 - Springer
Inactivation of tumor suppressor genes is an important event contributing to the development
of neoplasia. In addition to the classic genetic mechanisms of deletion or inactivating point …
of neoplasia. In addition to the classic genetic mechanisms of deletion or inactivating point …
DNA methylation as a therapeutic target in cancer
JPJ Issa - Clinical Cancer Research, 2007 - AACR
Targeting DNA methylation for cancer therapy has had a rocky history. The first reports on
DNA methylation changes in cancer described global loss of methylation, which has been …
DNA methylation changes in cancer described global loss of methylation, which has been …
Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications
V Santini, HM Kantarjian, JP Issa - Annals of internal medicine, 2001 - acpjournals.org
Methylation of DNA is a biochemical modification that can influence gene expression and is
involved in inactivating one of the two X chromosomes in women. Evidence that has …
involved in inactivating one of the two X chromosomes in women. Evidence that has …
The DNA methylation landscape of hematological malignancies: an update
P Blecua, L Martinez‐Verbo, M Esteller - Molecular Oncology, 2020 - Wiley Online Library
The rapid advances in high‐throughput sequencing technologies have made it more evident
that epigenetic modifications orchestrate a plethora of complex biological processes. During …
that epigenetic modifications orchestrate a plethora of complex biological processes. During …
DNA methylation profiles of lymphoid and hematopoietic malignancies
T Takahashi, N Shivapurkar, J Reddy… - Clinical cancer …, 2004 - AACR
Purpose: Aberrant methylation of the 5′ gene promoter regions is an epigenetic
phenomenon that is the major mechanism for silencing of tumor suppressor genes in many …
phenomenon that is the major mechanism for silencing of tumor suppressor genes in many …
DNA methylation and cancer therapy: new developments and expectations
M Esteller - Current opinion in oncology, 2005 - journals.lww.com
We are at the dawn of an era when epigenetic drugs will be an important weapon in our
arsenal in the war against cancer. Hematological malignancies have provided a promising …
arsenal in the war against cancer. Hematological malignancies have provided a promising …
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia
O Galm, S Wilop, C Lüders, E Jost, G Gehbauer… - Annals of …, 2005 - Springer
Hypermethylation of CpG islands near gene promoter regions is associated with
transcriptional inactivation and represents an important mechanism of gene silencing in …
transcriptional inactivation and represents an important mechanism of gene silencing in …
相关搜索
- hematologic malignancies dna methylation
- therapeutic target dna methylation
- changes in dna methylation
- hematologic disorders dna methylation
- therapeutic implications dna methylation
- cancer therapy dna methylation
- dna methylation in the treatment
- inhibitors of dna methylation
- aberrant dna methylation patterns
- dna methylation landscape
- dna methylation profiles
- secondary aml dna methylation
- older patients dna methylation
- epigenetic changes hematological malignancies